Lifebit Wins New Market Entrant at the British Business Awards 2026

Lifebit has won the New Market Entrant award at the British Business Awards 2026, presented by the British Chamber of Commerce in Japan (BCCJ) at its gala in early November.
The award recognizes Lifebit’s entry into Japan, where its federated Trusted Research Environment has been deployed with Mitsui Knowledge Industry at the University of Tokyo’s Institute of Medical Science.
Tokyo, Japan — November 19, 2026 — The British Business Awards are the BCCJ’s annual recognition of British business in Japan. The New Market Entrant category honors companies that have established themselves in the Japanese market, and the judges recognized Lifebit for having “entered Japan with ambition, strategic clarity and tangible commitment, creating early value while building strong potential for sustained success in the market.”
“The win was a complete surprise, but it reflects that the work of Lifebit in Japan is really taking shape and making an impact.”
Kent Zaitlik, Director of APAC, Lifebit

Bringing federated Trusted Research Environments to Japan
Lifebit works with Tokyo-based Mitsui Knowledge Industry to bring its Trusted Research Environments to Japan, supporting the country’s national goal of sharing genomic and clinical data across institutions by fiscal year 2029. Privacy law and institutional governance have historically kept that data in separate places. Lifebit’s federated approach makes it usable at a national scale without moving it across institutions or borders.
Through the alliance with Mitsui Knowledge Industry, the platform has been adapted to Japanese security and governance requirements and deployed at the University of Tokyo’s Institute of Medical Science.
Building local capability
With Mitsui Knowledge Industry, Lifebit delivers Japanese-language training, documentation and support, and is building skills in federated analysis and data standardization to the OMOP Common Data Model. Harmonizing electronic health records and other sources into a shared structure is what allows privacy-preserving observational research and real-world evidence generation without raw patient data leaving the institution that holds it.
Japanese partners have visited Genomics England and the NIHR Biomedical Research Centre in Cambridge, and Lifebit has advised on the technical and security requirements for Japan’s platforms. This year Lifebit also co-hosted a Trusted Research Environment conference in Tokyo with the University of Tokyo, Genomics England and Mitsui, and spoke at the UK–Japan Policy Dialogue on Critical Technologies.
Connecting Japan to international research
Lifebit is helping shape Japan’s platforms so they are compatible with those in the UK and Singapore, giving Japanese researchers a route into international studies while patient data stays protected. The approach is intended to support national research collaboration on cancer and rare diseases, across populations no single country could study alone.
A year of federated deployments
The Japan work sits alongside Lifebit’s other deployments this year. In July 2026, Lifebit won a five-year, £19.5 million contract to build the successor to the Genomics England research environment, which today holds 60 petabytes of data and serves more than 1,200 researchers. In October, the Department of Health – Abu Dhabi launched its Trusted Research Environment with Lifebit as a delivery partner, bringing together nearly 950,000 genomes and more than two billion clinical and claims records.
What comes next
Lifebit’s plan for Japan is for each new institution to join as its own secure environment, on the cloud of its choice, so the network grows without moving data or rebuilding.

“Japan has so much knowledge and insight … I foresee that Japan will be a huge contributor to the betterment of our technology: they’re going to be asking a lot of really good questions and testing everything again and again. Then the platform is going to become better and better, not just for Japan but for everyone.”
Kent Zaitlik, Director of APAC, Lifebit
About Lifebit
Lifebit is the Federated Trusted Research Environment for Sovereign AI. Governments, pharma, health systems, biobanks, and research consortia use Lifebit to analyze sensitive health data where it lives: data never leaves the source.
Source: British Chamber of Commerce in Japan, “BBA 2026 Winner Profile: New Market Entrant – Lifebit”, November 19, 2026. Read the full profile.
